Focused portfolio
Shared company capabilities support distinct products for movement analysis, occupational ergonomics, medical-device human factors, private performance review, and evidence-aware equipment discovery.
Review the portfolioResponsible company growth
Investors
A parent-company model for focused engineering products, developed with measured claims and explicit maturity.
Biosystems One welcomes non-confidential conversations with strategic investors, research funders, and partners aligned with engineering quality, scientific credibility, and responsible commercialization.
Evidence-led development
Public maturity, validation, limitations, privacy, and security boundaries reduce ambiguity between current capability and future roadmap.
Review the evidence modelCommercial discipline
Pricing and access reflect release maturity instead of invented tiers, false scarcity, or unsupported enterprise readiness.
Review pricing and accessTrust infrastructure
The Trust Center documents present controls, product-specific boundaries, incident response, reporting, and future assurance work.
Review the Trust CenterInformation available publicly
Company positioning, product maturity, research philosophy, trust disclosures, pricing and access, legal notices, brand assets, and contact routes are available for initial evaluation.
Information not represented
The website does not publish or imply revenue, customers, market share, funding raised, valuation, growth rates, awards, patents, financial forecasts, or investor returns.
Initial conversation
A useful inquiry identifies the organization, investment or funding thesis, relevant experience, expected role, and why Biosystems One is a potential fit. Initial submissions must remain non-confidential.
Investor inquiry
Start with alignment, not confidential materials.
Share a concise non-confidential overview of your organization and interest.